Malta vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Malta
100.0%
in 2023
Syrian Arab Republic
100.0%
in 2021
Malta rank
1st
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malta
- Syrian Arab Republic
How they compare
Malta currently reports 100.0% against 100.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 5 years both countries report, Syrian Arab Republic has been ahead every year.
Malta ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
Head to head by decade
| Decade | Malta | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malta or Syrian Arab Republic?
- Malta, at 100.0% against 100.0% in Syrian Arab Republic as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malta and Syrian Arab Republic?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Syrian Arab Republic?
- 5 years are reported by both, from 2007 to 2021.
- How do Malta and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malta ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.